What's in Fujian Akeylink Biotechnology Co., Ltd.'s pipeline?

Fujian Akeylink Biotechnology Co., Ltd. has 5 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 3 in Phase 1.

Which companies overlap with Fujian Akeylink Biotechnology Co., Ltd.'s portfolio?

Top competitors by shared drug class: Qilu Pharmaceutical Co., Ltd., Bio-Thera Solutions, Boryung Pharmaceutical Co., Ltd, Janssen Research & Development, LLC, Nanjing Zenshine Pharmaceuticals.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/fujian-akeylink-biotechnology-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Fujian Akeylink Biotechnology Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fujian Akeylink Biotechnology Co., Ltd. pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
GST-HG141	GST-HG141	phase 3	Bispecific monoclonal antibody		Oncology

Therapeutic area mix

Oncology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Qilu Pharmaceutical Co., Ltd. · 2 shared drug classes
Bio-Thera Solutions · 1 shared drug class
Boryung Pharmaceutical Co., Ltd · 1 shared drug class
Janssen Research & Development, LLC · 1 shared drug class
Nanjing Zenshine Pharmaceuticals · 1 shared drug class
PMG Pharm Co., Ltd · 1 shared drug class
Shanghai JMT-Bio Inc. · 1 shared drug class
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fujian Akeylink Biotechnology Co., Ltd.:

Cite this brief

Drug Landscape (2026). Fujian Akeylink Biotechnology Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/fujian-akeylink-biotechnology-co-ltd. Accessed 2026-05-17.